GRPH
Price:
$3.18
Market Cap:
$204.43M
Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to developing innovative therapeutic solutions for severe and life-threatening illnesses across the United States. Its primary investigational therapy, GPH101, is an autologous, gene-edited hematopoietic stem cell product specifically engineered to directly correct the underlying mutation causing sickle cell disease, thereby restoring normal adult hemoglobin production. The company's pipeline also features GPH201, intended for the treatment of X-linked severe combined immunodeficiency syndrome, and GPH301, an experimental candidate designed to address Gaucher disease, a genetic disorder characterized by a deficiency in the...[Read more]
Industry
Biotechnology
IPO Date
2021-06-25
Stock Exchange
NASDAQ
Ticker
GRPH
According to Graphite Bio, Inc.’s latest financial reports and current stock price. The company's current ROE is -46.82%. This represents a change of 313.51% compared to the average of -11.32% of the last 4 quarters.
The mean historical ROE of Graphite Bio, Inc. over the last ten years is 181.05%. The current -46.82% ROE has changed -125.86% with respect to the historical average. Over the past ten years (40 quarters), GRPH's ROE was at its highest in in the December 2020 quarter at 648.33%. The ROE was at its lowest in in the March 2026 quarter at -16.83%.
Average
181.05%
Median
44.73%
Minimum
-28.88%
Maximum
697.68%
Discovering the peaks and valleys of Graphite Bio, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 14.10%
Maximum Annual ROE = 697.68%
Minimum Annual Increase = -132.31%
Minimum Annual ROE = -28.88%
| Year | ROE | Change |
|---|---|---|
| 2025 | -28.88% | 18.44% |
| 2024 | -24.39% | -132.31% |
| 2023 | 75.47% | 68.72% |
| 2022 | 44.73% | -91.01% |
| 2021 | 497.82% | -28.65% |
| 2020 | 697.68% | 14.10% |
The current ROE of Graphite Bio, Inc. (GRPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.40%
5-year avg
112.95%
10-year avg
181.05%
Graphite Bio, Inc.’s ROE is greater than Theseus Pharmaceuticals, Inc. (-20.74%), greater than LakeShore Biopharma Co., Ltd (-18.43%), greater than Vaccitech plc (-63.87%), less than Zevra Therapeutics, Inc. (81.34%), greater than Alaunos Therapeutics, Inc. (-165.94%), greater than CARGO Therapeutics, Inc. Common Stock (-61.29%), greater than Spectrum Pharmaceuticals, Inc. (-207.06%), greater than F-star Therapeutics, Inc. (-44.74%), less than Graybug Vision, Inc. (4.09%), greater than eXoZymes, Inc. (-220.64%),
| Company | ROE | Market cap |
|---|---|---|
| -20.74% | $181.50M | |
| -18.43% | $25.84M | |
| -63.87% | $192.73M | |
| 81.34% | $747.81M | |
| -165.94% | $5.47M | |
| -61.29% | $216.19M | |
| -207.06% | $210.38M | |
| -44.74% | $156.51M | |
| 4.09% | $120.98M | |
| -220.64% | $62.91M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Graphite Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Graphite Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Graphite Bio, Inc.'s ROE?
How is the ROE calculated for Graphite Bio, Inc. (GRPH)?
What is the highest ROE for Graphite Bio, Inc. (GRPH)?
What is the 3-year average ROE for Graphite Bio, Inc. (GRPH)?
What is the 5-year average ROE for Graphite Bio, Inc. (GRPH)?
How does the current ROE for Graphite Bio, Inc. (GRPH) compare to its historical average?